Estimating the burden of SARS-CoV-2 in France
Open accessPublished version of a preprint
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
COVID-19 pandemic in France: Coronavirus disease 2019 (COVID-19) exacted a heavy toll in France during March and April 2020. Quarantine measures were effective in reducing transmission by 84%, and some relaxation of social isolation was expected in May. Salje et al. fit transmission models for the epidemic in France to hospital admissions. The authors forecast that 2.9 million people will have been infected by 11 May, representing 4.4% of the population—a value inadequate for herd immunity. Daily critical care hospitalizations should reduce from several hundreds to tens of cases, but control will remain a delicate balancing act. Any relaxation of lockdown in France will have to be carefully controlled and monitored to avoid undermining more optimistic forecasts. Science , this issue p. 208
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several studies have estimated cumulative infections in select countries at specific points in time.6, 7, 8, 9”
From Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis (2022) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gelman, A., Carlin, J. B., Stern, H. S., & Rubin, D. B. (2003) · doi:10.1201/9780429258480 · Cited by 27,276
Diekmann, O., Heesterbeek, J. A. P., & Metz, J. A. J. (1990) · Journal of Mathematical Biology · doi:10.1007/bf00178324 · Cited by 5,091
Yang, J., Zheng, Y., Gou, X., Pu, K., Chen, Z., Guo, Q., Ji, R., Wang, H., Wang, Y., & Zhou, Y. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.017 · Cited by 4,206
Estimates of the severity of coronavirus disease 2019: a model-based analysis
Verity, R., Okell, L. C., Dorigatti, I., Winskill, P., Whittaker, C., Imai, N., Cuomo-Dannenburg, G., Thompson, H., Walker, P. G. T., Fu, H., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30243-7 · Cited by 3,660
The effect of human mobility and control measures on the COVID-19 epidemic in China
Kraemer, M. U. G., Yang, C.-H., Gutierrez, B., Wu, C.-H., Klein, B., Pigott, D. M., Open COVID-19 Data Working Group, du Plessis, L., Faria, N. R., Li, R., et al. (2020) · Science · doi:10.1126/science.abb4218 · Cited by 2,950
Mizumoto, K., Kagaya, K., Zarebski, A., & Chowell, G. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.10.2000180 · Cited by 2,276
Tian, H., Liu, Y., Li, Y., Wu, C.-H., Chen, B., Kraemer, M. U. G., Li, B., Cai, J., Xu, B., Yang, Q., et al. (2020) · Science · doi:10.1126/science.abb6105 · Cited by 2,010
Bi, Q., Wu, Y., Mei, S., Ye, C., Zou, X., Zhang, Z., Liu, X., Wei, L., Truelove, S. A., Zhang, T., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30287-5 · Cited by 1,958
Self-citationLinton, N., Kobayashi, T., Yang, Y., Hayashi, K., Akhmetzhanov, A., Jung, S.-M., Yuan, B., Kinoshita, R., & Nishiura, H. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020538 · Cited by 1,361
How generation intervals shape the relationship between growth rates and reproductive numbers
Wallinga, J., & Lipsitch, M. (2007) · Proceedings of the Royal Society B: Biological Sciences · doi:10.1098/rspb.2006.3754 · Cited by 1,213
Cited by
Items 201–300 of 1,001
Shute, J. K. (2023) · Pharmaceuticals · doi:10.3390/ph16040584 · Cited by 54
Kumleben, N., Bhopal, R. S., Czypionka, T., Gruer, L. D., Kock, R. A., Stebbing, J., & Stigler, F. L. (2020) · Public Health · doi:10.1016/j.puhe.2020.06.006 · Cited by 53
Lockdown, essential sectors, and Covid-19: Lessons from Italy
Porto, E. D., Naticchioni, P., & Scrutinio, V. (2021) · Journal of Health Economics · doi:10.1016/j.jhealeco.2021.102572 · Cited by 47
McPartlin, S. O., Morrison, J., Rohrig, A., & Weijer, C. (2020) · BMJ · doi:10.1136/bmj.m4258 · Cited by 45
Using excess deaths and testing statistics to determine COVID-19 mortalities
Böttcher, L., D'Orsogna, M. R., & Chou, T. (2021) · European Journal of Epidemiology · doi:10.1007/s10654-021-00748-2 · Cited by 52
Vaccination and COVID-19 Dynamics in Dialysis Patients
Karoui, K. E., Hourmant, M., Ayav, C., Glowacki, F., Couchoud, C., Lapidus, N., & on behalf of the REIN Registry (2022) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.10300721 · Cited by 53
Mortality containment vs. Economics Opening: Optimal policies in a SEIARD model
Aspri, A., Beretta, E., Gandolfi, A., & Wasmer, É. (2021) · Journal of Mathematical Economics · doi:10.1016/j.jmateco.2021.102490 · Cited by 50
Galmiche, S., Rahbé, E., Fontanet, A. L., Dinh, A., Bénézit, F., Lescure, F.-X., & Denis, F. (2020) · Journal of Medical Internet Research · doi:10.2196/22924 · Cited by 49
Self-citationFirst Wave of COVID-19 in French Patients with Cystic Fibrosis
Corvol, H., de Miranda, S., Lemonnier, L., Kemgang, A., Reynaud‐Gaubert, M., Chiron, R., Dalphin, M., Durieu, I., Dubus, J. ‐., Houdouin, V., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113624 · Cited by 46
Jamison, J., Bundy, D. A. P., Jamison, D. T. T., Spitz, J., & Verguet, S. (2020) · Health Services Research · doi:10.1111/1475-6773.13688 · Cited by 51
Palmer, S., Cunniffe, N. J., & Donnelly, R. (2021) · Journal of The Royal Society Interface · doi:10.1098/rsif.2020.0982 · Cited by 50
Group testing as a strategy for COVID-19 epidemiological monitoring and community surveillance
Brault, V., Mallein, B., & Rupprecht, J.-F. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008726 · Cited by 48
A demographic scaling model for estimating the total number of COVID-19 infections
Bohk-Ewald, C., Dudel, C., & Myrskylä, M. (2020) · International Journal of Epidemiology · doi:10.1093/ije/dyaa198 · Cited by 45
Bosetti, P., Kiem, C. T., Yazdanpanah, Y., Fontanet, A. L., Lina, B., Vittoria Colizza, A., & Cauchemez, S. (2021) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.26.1.2001978 · Cited by 44
Self-citationCapistrán, M. A., Capella, A., & Christen, J. A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0245669 · Cited by 47
Sypsa, V., Roussos, S., Paraskevis, D. N., Lytras, T., Tsiodras, S., & Hatzakis, A. E. (2021) · Emerging infectious diseases · doi:10.3201/eid2702.203412 · Cited by 45
for the SAPRIS study group, Carrat, F., Touvier, M., Severi, G., Meyer, L., Jusot, F., Lapidus, N., Rahib, D., Lydié, N., Charles, M.-A. A., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-05864-8 · Cited by 49
Crawford, F. W., Jones, S., Cartter, M. L., Dean, S. G., Warren, J. L., Li, Z. R., Barbieri, J., Campbell, J., Kenney, P., Valleau, T., et al. (2022) · Science Advances · doi:10.1126/sciadv.abi5499 · Cited by 57
Toubiana, J., Cohen, J. F., Brice, J., Poirault, C., Bajolle, F., Curtis, W., Moulin, F., Matczak, S., Leruez, M., Casanova, J.-L., et al. (2021) · Journal of Clinical Immunology · doi:10.1007/s10875-020-00941-0 · Cited by 43
Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020
Halatoko, W. A., Konu, Y. R., Gbeasor‐Komlanvi, F. A., Sadio, A. J., Tchankoni, M. K., Komlanvi, K. S., Salou, M., Dorkenoo, A. M., Maman, I., Agbobli, A., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242124 · Cited by 42
Mahajan, A., Solanki, R., & Sivadas, N. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26897 · Cited by 42
COVID-19: Spatial analysis of hospital case-fatality rate in France
Souris, M., & Gonzalez, J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0243606 · Cited by 42
McCabe, R., Kont, M. D., Schmit, N., Whittaker, C., Løchen, A., Baguelin, M., Knock, E., Whittles, L. K., Lees, J. A., Brazeau, N. F., et al. (2021) · International Journal of Epidemiology · doi:10.1093/ije/dyab034 · Cited by 44
Castro, M. C., Gurzenda, S., Macário, E. M., & de França, G. V. A. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-049089 · Cited by 50
Banholzer, N., Lison, A., Özcelik, D., Stadler, T., Feuerriegel, S., & Vach, W. (2022) · European Journal of Epidemiology · doi:10.1007/s10654-022-00908-y · Cited by 41
Observational Study of Chlorpromazine in Hospitalized Patients with COVID-19
Hoertel, N., Rico, M. S., Vernet, R., Jannot, A., Neuraz, A., Blanco, C., Lemogne, C., Airagnes, G., Paris, N., Daniel, C., et al. (2021) · Clinical Drug Investigation · doi:10.1007/s40261-021-01001-0 · Cited by 48
Xu, W., Zhang, F., Shi, Y., Chen, Y., Shi, B., & Yu, G. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.989950 · Cited by 45
Manshadi, V., Niazadeh, R., & Rodilitz, S. (2021) · Management Science · doi:10.1145/3465456.3467554 · Cited by 65
Impact of COVID-19 on motor vehicle injuries and fatalities in older adults in Ontario, Canada
Rapoport, M. J., Chee, J. N., Aljenabi, N., Byrne, P., Naglie, G., Ilari, F., Elzohairy, Y., Vingilis, E. R., & Mulsant, B. H. (2021) · Accident Analysis & Prevention · doi:10.1016/j.aap.2021.106195 · Cited by 43
Domenico, L. D., Sabbatini, C. E., Boëlle, P., Poletto, C., Crépey, P., Paireau, J., Cauchemez, S., Beck, F., Noël, H., Lévy-Bruhl, D., et al. (2021) · Communications Medicine · doi:10.1038/s43856-021-00057-5 · Cited by 50
Self-citationBroad cross-national public support for accelerated COVID-19 vaccine trial designs
Broockman, D., Kalla, J., Guerrero, A., Budolfson, M. B., Eyal, N., Jewell, N. P., Magalhães, M., & Sekhon, J. S. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.11.072 · Cited by 41
Lefrancq, N., Paireau, J., Hozé, N., Courtejoie, N., Yazdanpanah, Y., Bouadma, L., Boëlle, P., Chéreau, F., Salje, H., & Cauchemez, S. (2021) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2021.100087 · Cited by 41
Self-citationChloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidence
Roustit, M., Guilhaumou, R., Molimard, M., Drici, M., Laporte, S., & Montastruc, J. (2020) · Therapies · doi:10.1016/j.therap.2020.05.010 · Cited by 41
Protective reactive thymus hyperplasia in COVID-19 acute respiratory distress syndrome
Cuvelier, P., Roux, H., Couëdel-Courteille, A., Dutrieux, J., Naudin, C., Muylder, B. C.-D., Cheynier, R., Squara, P., & Marullo, S. (2021) · Critical Care · doi:10.1186/s13054-020-03440-1 · Cited by 43
Agent-based modelling of reactive vaccination of workplaces and schools against COVID-19
Faucher, B., Assab, R., Roux, J., Lévy-Bruhl, D., Kiem, C. T., Cauchemez, S., Zanetti, L. C. D. S., Colizza, V., Boëlle, P., & Poletto, C. (2022) · Nature Communications · doi:10.1038/s41467-022-29015-y · Cited by 43
Self-citationHamou, A. A., Rasul, R. R. Q., Hammouch, Z., & Özdemir, N. (2022) · Computational and Applied Mathematics · doi:10.1007/s40314-022-01990-4 · Cited by 46
Negative SARS-CoV-2 PCR in patients with chilblain-like lesions
Hubiche, T., Duff, F. L., Chiavérini, C., Giordanengo, V., & Passeron, T. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30518-1 · Cited by 40
Ghazy, R. M., ElHafeez, S. A., Shaaban, R., Elbarazi, I., Kheirallah, K. A., Abdou, M. S. M., & Ramadan, A. (2021) · Journal of Primary Care & Community Health · doi:10.1177/21501327211018568 · Cited by 41
Emmenegger, M., Cecco, E. D., Lamparter, D., Jacquat, R. P. B., Riou, J., Menges, D., Ballouz, T., Ebner, D. V., Schneider, M. M., Morales, I. C., et al. (2023) · iScience · doi:10.1101/2020.05.31.20118554 · Cited by 34
An international initiative of predicting the SARS-CoV-2 pandemic using ensemble data assimilation
Evensen, G., Amezcua, J., Bocquet, M., Carrassi, A., Farchi, A., Fowler, A., Houtekamer, P. L., Jones, C. K. R. T., de Moraes, R. J., Pulido, M., et al. (2020) · Foundations of Data Science · doi:10.3934/fods.2021001 · Cited by 42
Leal, F. E., Mendes-Corrêa, M. C., Buss, L., Costa, S. F., Bizário, J. C. S., de Souza, S. R. P., Thomaz, O., Tozetto‐Mendoza, T. R., Villas-Boas, L. S., Silva, L. C. D. O.-D., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-042745 · Cited by 42
Landecho, M. F., Marín‐Oto, M., Zamacona, B. R., Bilbao, I., & Frühbeck, G. (2021) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2021.03.031 · Cited by 51
The COVID-19 vaccination experience in Bangladesh: Findings from a cross-sectional study
Islam, M. R., Hasan, M., Nasreen, W., Tushar, M. I., & Bhuiyan, M. A. (2021) · International Journal of Immunopathology and Pharmacology · doi:10.1177/20587384211065628 · Cited by 40
Estimating the state of the COVID-19 epidemic in France using a model with memory
Forien, R., Pang, G., & Pardoux, É. (2021) · Royal Society Open Science · doi:10.1098/rsos.202327 · Cited by 39
Landier, J., Paireau, J., Rebaudet, S., Legendre, E., Lehot, L., Fontanet, A. L., Cauchemez, S., & Gaudart, J. (2021) · Scientific Reports · doi:10.1038/s41598-021-91798-9 · Cited by 45
Self-citationWells, C. R., Pandey, A., Fitzpatrick, M. C., Crystal, W., Singer, B. H., Moghadas, S. M., Galvani, A. P., & Townsend, J. P. (2022) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2021.100304 · Cited by 39
Les inégalités sociales au temps du COVID-19
Bajos, N., Warszawski, J., Pailhé, A., Counil, É., Jusot, F., Spire, A., Martin, C., Meyer, L., Sireyjol, A., Franck, J.-E., et al. (2020) · Questions de santé publique · doi:10.1051/qsp/2020040 · Cited by 51
SARS-CoV-2 transmission across age groups in France and implications for control
Kiem, C. T., Bosetti, P., Paireau, J., Crépey, P., Salje, H., Lefrancq, N., Fontanet, A. L., Benamouzig, D., Boëlle, P., Desenclos, J. C., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27163-1 · Cited by 43
Self-citationOne year of modeling and forecasting COVID-19 transmission to support policymakers in Connecticut
Morozova, O., Li, Z. R., & Crawford, F. W. (2021) · Scientific Reports · doi:10.1038/s41598-021-99590-5 · Cited by 37
Fiore, J. R., Centra, M., Carlo, A. D., Granato, T., Rosa, A., Sarno, M., Feo, L. D., Stefano, M. D., Errico, M. D., Caputo, S. L., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26425 · Cited by 32
Bourguiba, R., Delplanque, M., Vinit, C., Ackermann, F., Savey, L., Grateau, G., Hentgen, V., & Georgin‐Lavialle, S. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-218707 · Cited by 36
In War Times: Fictionalizing Iraq
Luckhurst, R. (2012) · Contemporary Literature · doi:10.1353/cli.2012.0040 · Cited by 53
Optimal Immunity Control and Final Size Minimization by Social Distancing for the SIR Epidemic Model
Bliman, P., Duprez, M., Privat, Y., & Vauchelet, N. (2021) · Journal of Optimization Theory and Applications · doi:10.1007/s10957-021-01830-1 · Cited by 36
Nowcasting COVID-19 incidence indicators during the Italian first outbreak
Loro, P. A. D., Divino, F., Farcomeni, A., Lasinio, G. J., Lovison, G., Maruotti, A., & Mingione, M. (2021) · PubMed Central · doi:10.5451/unibas-ep88920 · Cited by 36
Risk factors for pulmonary embolism in patients with COVID-19: a systemic review and meta-analysis
Cui, Y., Cheng, W., Mou, Z., Xiao, D., Li, Y., Li, Y., Li, W.-T., & Chen, Z. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.08.017 · Cited by 43
Estimative of real number of infections by COVID-19 in Brazil and possible scenarios
Cintra, P. H. P., & Fontinele, F. N. (2020) · Infectious Disease Modelling · doi:10.1016/j.idm.2020.09.004 · Cited by 39
Hesni, E., Sayad, B., Shadmani, F. K., Najafi, F., Khodarahmi, R., Rahimi, Z., Bozorgomid, A., & Sayad, N. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07312-7 · Cited by 36
Liu, Y., Procter, S. R., Pearson, C. A. B., Montero, A. M., Rueda, S. T., Zegeye, E. A., Uzochukwu, B. S. C., Drake, T. L., Bergren, E., Eggo, R. M., et al. (2023) · BMC Medicine · doi:10.1186/s12916-023-02784-z · Cited by 39
Porta, C. A. M. L., & Zapperi, S. (2020) · Cell Systems · doi:10.1016/j.cels.2020.08.011 · Cited by 40
To quarantine, or not to quarantine: A theoretical framework for disease control via contact tracing
Lunz, D., Batt, G., & Ruess, J. (2020) · Epidemics · doi:10.1016/j.epidem.2020.100428 · Cited by 34
Data curation during a pandemic and lessons learned from COVID-19
Kraemer, M. U. G., Scarpino, S. V., Marivate, V. N., Gutiérrez, B., Xu, B., Graham, L., Hawkins, J. B., Rivers, C., Pigott, D. M., Katz, R., et al. (2021) · Nature Computational Science · doi:10.1038/s43588-020-00015-6 · Cited by 35
Schoenhals, M. J., Rabenindrina, N., Rakotondramanga, J. M., Dussart, P., Randremanana, R. V., Héraud, J., Andriamandimby, S. F., Sahondranirina, P. H., Vololoniaina, M. C., Randriatsarafara, F. M., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103419 · Cited by 34
Watson, J. A., Kissler, S. M., Day, N., Grad, Y. H., & White, N. J. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00192-22 · Cited by 33
Estimating SARS‐CoV‐2 infections and associated changes in COVID‐19 severity and fatality
Marziano, V., Guzzetta, G., Menegale, F., Sacco, C., Petrone, D., Mateo‐Urdiales, A., Manso, M. D., Bella, A., Fabiani, M., Vescio, M. F., et al. (2023) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.13181 · Cited by 35
SARS-CoV-2/COVID-19 – Epidemiologie und Prävention
Salzberger, B., Buder, F., Lampl, B. M. J., Ehrenstein, B. P., Hitzenbichler, F., Holzmann, T., Schmidt, B., & Hanses, F. (2020) · Der Nephrologe · doi:10.1007/s11560-020-00472-0 · Cited by 43
Resistance of children to Covid-19. How?
Fischer, A. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-0303-9 · Cited by 41
Montalva, L., Haffreingue, A., Ali, L., Clariot, S., Julien‐Marsollier, F., El‐Ghoneimi, A., Peycelon, M., & Bonnard, A. (2020) · Pediatric Surgery International · doi:10.1007/s00383-020-04759-0 · Cited by 34
Impact of January 2021 curfew measures on SARS-CoV-2 B.1.1.7 circulation in France
Domenico, L. D., Sabbatini, C. E., Pullano, G., Lévy-Bruhl, D., & Colizza, V. (2021) · Eurosurveillance · doi:10.2807/1560-7917.es.2021.26.15.2100272 · Cited by 42
Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection
Yatim, N., Boussier, J., Tétu, P., Smith, N., Bruel, T., Charbit, B., Barnabei, L., Corneau, A., Meda, L. D., Allayous, C., et al. (2021) · Science Advances · doi:10.1126/sciadv.abg4081 · Cited by 37
Point-of-Care Toolkit for Multiplex Molecular Diagnosis of SARS-CoV-2 and Influenza A and B Viruses
Lee, D., Chu, C., & Sarioglu, A. F. (2021) · ACS Sensors · doi:10.1021/acssensors.1c00702 · Cited by 35
Post lockdown COVID-19 seroprevalence and circulation at the time of delivery, France
Mattern, J., Vauloup‐Fellous, C., Zakaria, H., Benachi, A., Carrara, J., Letourneau, A., Bourgeois‐Nicolaos, N., Luca, D. D., Doucet‐Populaire, F., & Vivanti, A. J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240782 · Cited by 33
Booton, R. D., MacGregor, L., Vass, L., Looker, K. J., Hyams, C. J., Bright, P., Harding, I., Lazarus, R., Hamilton, F., Lawson, D. J., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-041536 · Cited by 37
Yan, F.-F., & Gao, F. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab044 · Cited by 33
Terrier, C., Chen, D. L., & Sutter, M. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2110891118 · Cited by 31
Mobility Reduction and Covid-19 Transmission RatesPreprint
BERGMAN, N. K., & Fishman, R. (2020) · medRxiv · doi:10.1101/2020.05.06.20093039 · Cited by 34
Communicating uncertainty in epidemic models
McCabe, R., Kont, M. D., Schmit, N., Whittaker, C., Løchen, A., Walker, P. G. T., Ghani, A. C., Ferguson, N. M., White, P. J., Donnelly, C. A., et al. (2021) · Epidemics · doi:10.1016/j.epidem.2021.100520 · Cited by 39
Halting SARS-CoV-2 by Targeting High-Contact Individuals
Manzo, G., & van de Rijt, A. (2020) · RePEc: Research Papers in Economics · Cited by 32
By the COVID-19 APHP-Universities-INRIA-INSERM Group, & Riou, B. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241406 · Cited by 40
Inference of COVID-19 epidemiological distributions from Brazilian hospital data
Hawryluk, I., Mellan, T. A., Hoeltgebaum, H., Mishra, S., Schnekenberg, R. P., Whittaker, C., Zhu, H., Gandy, A., Donnelly, C. A., Flaxman, S. R., et al. (2020) · Journal of The Royal Society Interface · doi:10.1098/rsif.2020.0596 · Cited by 30
Dynamics of SARS-CoV-2 with waning immunity in the UK population
Crellen, T., Pi, L., Davis, E. L., Pollington, T. M., Lucas, T. C. D., Ayabina, D. V., Borlase, A., Toor, J., Prem, K., Medley, G. F., et al. (2021) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2020.0274 · Cited by 33
Pfeifer, M. A., & Hamer, O. W. (2020) · Der Internist · doi:10.1007/s00108-020-00854-5 · Cited by 44
Ebrahim, S. H., Gozzer, E., Ahmed, Y., Imtiaz, R., Ditekemena, J., Rahman, N. M. M., Schlagenhauf, P., Alqahtani, S. A., & Memish, Z. A. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.10.055 · Cited by 32
A parsimonious approach for spatial transmission and heterogeneity in the COVID-19 propagation
Roques, L., Bonnefon, O., Baudrot, V., Soubeyrand, S., & Berestycki, H. (2020) · Royal Society Open Science · doi:10.1098/rsos.201382 · Cited by 34
Ayoub, H. H., Chemaitelly, H. S., Makhoul, M., Kanaani, Z. A., Al‐Kuwari, E., Butt, A. A., Coyle, P. V., Jeremijenko, A. M., Kaleeckal, A. H., Latif, A. N., et al. (2021) · BMJ Innovations · doi:10.1136/bmjinnov-2021-000677 · Cited by 31
Common communicable diseases in the general population in France during the COVID-19 pandemic
Launay, T., Souty, C., Vilcu, A., Turbelin, C., Blanchon, T., Guerrisi, C., Hanslik, T., Colizza, V., Bardoulat, I., Lemaître, M., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0258391 · Cited by 42
Optimal vaccine allocation for COVID-19 in the Netherlands: A data-driven prioritization
Miura, F., Leung, K. Y., Klinkenberg, D., Ainslie, K. E. C., & Wallinga, J. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1009697 · Cited by 30
Sofonea, M. T., Reyné, B., Elie, B., Djidjou‐Demasse, R., Selinger, C., Michalakis, Y., & Alizon, S. (2020) · medRxiv · doi:10.1101/2020.05.22.20110593 · Cited by 31
Risk Factors for Long COVID in Older Adults
Hu, Y., Liu, Y., Zheng, H., & Liu, L. (2023) · Biomedicines · doi:10.3390/biomedicines11113002 · Cited by 42
Hospital and Population-Based Evidence for COVID-19 Early Circulation in the East of France
Gerbaud, L., Guiguet‐Auclair, C., Breysse, F., Odoul, J., Ouchchane, L., Peterschmitt, J., Dezfouli-Desfer, C., & Breton, V. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17197175 · Cited by 33
Epidemiological Differences in the Impact of COVID-19 Vaccination in the United States and China
Makhoul, M., Chemaitelly, H. S., Ayoub, H. H., Seedat, S., & Abu-Raddad, L. J. (2021) · Vaccines · doi:10.3390/vaccines9030223 · Cited by 29
Exploring Risks of Human Challenge Trials For COVID‐19
Manheim, D., Więcek, W., Schmit, V. L., & Morrison, J. (2021) · Risk Analysis · doi:10.1111/risa.13726 · Cited by 31
Comparative Study of Government Response Measures and Epidemic Trends for COVID‐19 Global Pandemic
Wang, C., Zhang, H., Gao, Y., & Deng, Q. (2021) · Risk Analysis · doi:10.1111/risa.13817 · Cited by 37
Disease transmission and control modelling at the science–policy interface
McCabe, R., & Donnelly, C. A. (2021) · Interface Focus · doi:10.1098/rsfs.2021.0013 · Cited by 26
Covid-19 Aphp-Universities-Inria-Inserm Group, C. N. (2020) · HAL · Cited by 30
Decerf, B., Ferreira, F. H. G., Mahler, D. G., & Sterck, O. C. (2020) · World Bank, Washington, DC eBooks · doi:10.1596/1813-9450-9277 · Cited by 32
Coronavirus Human Infection Challenge Studies: Assessing Potential Benefits and Risks
Jamrozik, E., Heriot, G., & Selgelid, M. J. (2020) · Journal of Bioethical Inquiry · doi:10.1007/s11673-020-10030-x · Cited by 29
Ahmed, R., Williamson, M., Hamid, M. A., & Ashraf, N. (2020) · Healthcare · doi:10.3390/healthcare8030330 · Cited by 32
Standards of evidence for institutional review board decision-making
Resnik, D. B. (2020) · Accountability in Research · doi:10.1080/08989621.2020.1855149 · Cited by 42
Laydon, D. J., Mishra, S., Hinsley, W. R., Samartsidis, P., Flaxman, S. R., Gandy, A., Ferguson, N. M., & Bhatt, S. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-050346 · Cited by 30
Syal, S. (2021) · Journal of Urban Management · doi:10.1016/j.jum.2021.05.004 · Cited by 37
Metadata
- Authors
- Salje, H., Tran Kiem, C., Lefrancq, N., Courtejoie, N., Bosetti, P., Paireau, J., Andronico, A., Hozé, N., Richet, J., Dubost, C.-L., Le Strat, Y., Lessler, J., Levy-Bruhl, D., Fontanet, A., Opatowski, L., Boelle, P.-Y., & Cauchemez, S.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Mathematical Modelling of Infectious Diseases Unit, Institut Pasteur, UMR2000, CNRS, Paris, France.
- Ministère des Solidarités et de la Santé (FR)
- Santé Publique France, French National Public Health Agency, Saint-Maurice, France.
- Johns Hopkins University (US)
- Conservatoire National des Arts et Métiers (FR)
- Inserm (FR)
- Institut Pierre Louis d’Epidémiologie et de Santé Publique, Sorbonne Université, INSERM, Paris, France.
- Corresponding author
- Cauchemez, Simon
- ORCID
- Venue
- Science
- Published
- 2020-07-10
- Volume
- 369
- Issue
- 6500
- Pages
- 208-211
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC7223792
- OpenAlex
- W3025090814
- Cited by
- 1,038
- References
- 30
- Citations by year
- 2026: 15 · 2025: 29 · 2024: 50 · 2023: 90 · 2022: 171 · 2021: 378 · 2020: 303
- FWCI
- 37.42
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Science (publishedVersion, cc-by)
- medRxiv (acceptedVersion, cc-by-nd)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by-nc-nd)
- HAL (submittedVersion, cc-by-nc)
- Funders
- H2020 European Research Council (804744)
- ANR (ANR-10-LABX-62-IBEID)
- INCEPTION (PIA/ANR-16-CONV-0005)
- Santé Publique France
- European Union RECOVER
- University of Cambridge COVID-19 Rapid Response Grant
- Topics
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- SARS-CoV-2, COVID-19 pandemic, hospitalization rates, mortality rates, lockdown, reproduction number, herd immunity, age and sex differences, intensive care, second wave, France
- MeSH terms
- COVID-19, Adolescent, Adult, Aged, Aged, 80 and over, Critical Care, Female, France, Hospitalization, Humans, Immunity, Male, Middle Aged, Pneumonia, Viral, Quarantine, Cost of Illness, Coronavirus Infections, Severe acute respiratory syndrome-related coronavirus, Young Adult, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.